NCT00715780View on ClinicalTrials.gov

Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents

CompletedOBSERVATIONAL
Enrollment

1,667

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

soluble human insulin

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

biphasic human insulin

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

insulin NPH

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

insulin aspart

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

biphasic insulin aspart

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

DRUG

insulin detemir

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

Trial Locations (1)

12520

Novo Nordisk Investigational Site, Jakarta

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY